Johnson & Johnson (JNJ.N), which has been beset by a series of massive recalls of its consumer healthcare products, unloaded one of them on Friday, selling its St Joseph's aspirin brand. The 145-year-old brand, which J&J acquired from Schering-Plough Corp in 2000, was bought by Ilex Consumer Products Group and JPB Capital Partners, a private equity firm. Terms of the deal were not disclosed and none of the parties involved would divulge annual revenue figures for the product, which J&J does not break out in its financial reports. St Joseph's aspirin was made by McNeil Consumer Healthcare, the J&J unit at the center of recalls of millions of bottles of widely used products, such as Tylenol, Motrin and Rolaids, due to quality control problems and other manufacturing issues.
Source
